Exploring LBCL: Transplant Eligibility and Second Line Treat

Fred Locke, MD, provides an overview of transplant eligibility for patients with large B-cell lymphoma, highlighting second line strategies with CAR T-cell therapy and bispecific antibodies.

Related Keywords

, Transforming Largeb Cell Lymphoma , Novel Agents , Transplant Eligibility , Second Line Treatment Selection , Dlbcl , Lymphoma , Largeb Cell Lymphoma , Car T , Cart Cell , Cart Cell Therapy , Cart Cell Therapy Lymphoma , Cart Cell Therapy Largeb Lymphoma , Patients With Lbcl , Patients With Largeb Cell Lymphoma , Mechanisms Of Action , Clinical Applications ,